Sign in
Groups
Researchers
Results
Sergio
Ruiz Llorente
Profesor/a Ayudante Doctor/a
Eli Lilly and Company
Indianapolis, EE. UU.
You are in
Collaborations
Eli Lilly and Company
Publications in collaboration with researchers from Eli Lilly and Company (1)
2016
NSD2 contributes to oncogenic RAS-driven transcription in lung cancer cells through long-range epigenetic activation
Scientific Reports, Vol. 6
Contact
Legal notice
translate
en
arrow_drop_down
translate
en
arrow_drop_down
es
ca
eu
gl
fr
de